tivicay pd

Generic: dolutegravir sodium

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name tivicay pd
Generic Name dolutegravir sodium
Labeler viiv healthcare company
Dosage Form TABLET, FOR SUSPENSION
Routes
ORAL
Active Ingredients

dolutegravir sodium 5 mg/1

Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-255
Product ID 49702-255_a9175b83-2200-4bd2-9ee3-52095b5d2657
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA213983
Listing Expiration 2026-12-31
Marketing Start 2020-06-12

Pharmacologic Class

Classes
hiv integrase inhibitors [moa] human immunodeficiency virus integrase strand transfer inhibitor [epc] multidrug and toxin extrusion transporter 1 inhibitors [moa] organic cation transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702255
Hyphenated Format 49702-255

Supplemental Identifiers

RxCUI
1433873 1433879 1796077 1796079 1796081 1796083 2374562 2374566
UPC
0349702227132 0349702226135 0349702228139
UNII
1Q1V9V5WYQ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tivicay pd (source: ndc)
Generic Name dolutegravir sodium (source: ndc)
Application Number NDA213983 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (49702-255-37) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE
source: ndc

Packages (1)

49702-255-37 1 BOTTLE in 1 CARTON (49702-255-37) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE

Ingredients (1)

dolutegravir sodium (5 mg/1)

Linked Drug Pages (1)

Tivicay, Tivicay PD ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a9175b83-2200-4bd2-9ee3-52095b5d2657", "openfda": {"upc": ["0349702227132", "0349702226135", "0349702228139"], "unii": ["1Q1V9V5WYQ"], "rxcui": ["1433873", "1433879", "1796077", "1796079", "1796081", "1796083", "2374562", "2374566"], "spl_set_id": ["63df5af3-b8ac-4e76-9830-2dbb340af922"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (49702-255-37)  / 60 TABLET, FOR SUSPENSION in 1 BOTTLE", "package_ndc": "49702-255-37", "marketing_start_date": "20200612"}], "brand_name": "Tivicay PD", "product_id": "49702-255_a9175b83-2200-4bd2-9ee3-52095b5d2657", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["HIV Integrase Inhibitors [MoA]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49702-255", "generic_name": "dolutegravir sodium", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tivicay PD", "active_ingredients": [{"name": "DOLUTEGRAVIR SODIUM", "strength": "5 mg/1"}], "application_number": "NDA213983", "marketing_category": "NDA", "marketing_start_date": "20200612", "listing_expiration_date": "20261231"}